Use of ruthenium complexes for formation and/or hydrogenation of amides and related carboxylic acid derivatives

US9290441B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9290441-B2
Application numberUS-201213471037-A
CountryUS
Kind codeB2
Filing dateMay 14, 2012
Priority dateOct 30, 2007
Publication dateMar 22, 2016
Grant dateMar 22, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A process for preparing amides by reacting a primary amine and a primary alcohol in the presence of a Ruthenium complex to generate the amide and molecular hydrogen. Primary amines are directly acylated by equimolar amounts of alcohols to produce amides and molecular hydrogen (the only byproduct) in high yields and high turnover numbers. Also disclosed are processes for hydrogenation of amides to alcohols and amines; hydrogenation of organic carbonates to alcohols; hydrogenation of carbamates or urea derivatives to alcohols and amines; amidation of esters; acylation of alcohols using esters; coupling of alcohols with water and a base to form carboxylic acids; dehydrogenation of beta-amino alcohols to form pyrazines and cyclic dipeptides; and dehydrogenation of secondary alcohols to ketones. These reactions are catalyzed by a Ruthenium complex which is based on a dearomatized PNN-type ligand of formula A1 or precursors thereof of formulae A2 or A3.

First claim

Opening claim text (preview).

What is claimed is: 1. A process for hydrogenating an amide to generate an alcohol and amine, which process comprises reacting the amide with molecular hydrogen (H 2 ), in the absence of a solvent or in a solvent system consisting of an organic solvent, in the presence of a Ruthenium complex represented by the structure of formula A1′, A2′ or A3′: wherein L 1 is N(R) 2 ; L 2 is selected from the group consisting of nucleophilic carbene (:CR 2 ), P(R 2 ), P(OR) 2 , N(R) 2 , imine, SR, SH, S(═O)R, heteroaryl wherein the heteroatom is selected from nitrogen and sulfur, As(R 2 ), Sb(R) 2 and an N-heterocyclic carbene represented by the structure: wherein each of R, R 1 , R 2 and R 3 are independently selected from the group consisting of alkyl, cycloalkyl, aryl, alkylaryl, heterocyclyl and heteroaryl; L 3 is a mono-dentate two-electron donor selected from the group consisting of CO, P(R) 3 , P(OR) 3 , NO + , As(R) 3 , Sb(R) 3 , S(R) 2 , nitrile (RCN) and isonitrile (RNC) wherein R is as defined above; L 4 is absent or is L 3 ; Y and Z are each independently H or an anionic ligand selected from the group consisting of halogen, OCOR, OCOCF 3 , OSO 2 R, OSO 2 CF 3 , CN, OH, OR, N(R 2 ), RS and SH; wherein R is as defined above; X represents zero, one, two or three substituents selected from the group consisting of alkyl, aryl, halogen, nitro, amide, ester, cyano, alkoxy, cycloalkyl, alkylaryl, heterocyclyl, heteroaryl, an inorganic support and a polymeric moiety; and anion represents a group bearing a single negative charge wherein the process comprises the step of hydrogenating an amide represented by the formula R 4 C(═O)—N—R 5 R 5′ to an alcohol of formula R 4 CH 2 OH and amine of formula R 5 R 5′ NH: wherein R 4 , R 5 and R 5′ are each independently selected from the group consisting of H, an unsubstituted or substituted alkyl, alkoxyalkyl, cycloalkyl, aryl, alkylaryl, heterocyclyl and heteroaryl. 2. The process of claim 1 , wherein the process is conducted either with (a) Ruthenium complex A1′ in the absence of a base; or (b) Ruthenium complex A2′ or A3′ in the presence of one or two equivalents of base relative to the amount of the Ruthenium complex. 3. The process of claim 1 , wherein the complex is represented by the structure of formula 1: 4. The process of claim 1 , wherein the amide is selected from the group consisting of N-benzyl-2-methoxyacetamide, N-hexyl-2-methoxyacetamide, N-hexyl-3-methyloxetane-3-carboxamide, N-hexyl-2-furanylcarboxamide, N-benzylbenzamide, N-ethylacetamide, N-methylpropionamide, N-cyclohexyl-2-methoxyacetamide, N-phenylacetamide, N-phenylhexylamide, 2-methoxy-N-phenylacetamide, N-phenylbenzamide, Ethylenediamine-N,N′-(2-methoxyacetamide), N-hexanoylmorpholine, N-butanoylmorpholine, N-2-metoxyacetylpyrrolidine, N-formylmorpholine, N,N-dimethylformamide, N,N-diethylbenzamide, benzamide, 4-methylbenzamide, cyclohexanecarboxamide, hexanamide, acetamide, acrylamide and pivalamide. 5. The process of claim 1 , wherein when the amide is a cyclic amide (lactam), the process results in an amino alcohol, or wherein the amide is a polyamide or a polypeptide. 6. A process for hydrogenating an organic carbonate represented by the formula R 8 O—C(═O)—OR 8′ to the corresponding alcohols(s) and methanol: wherein R 8 and R 8′ are the same or different and are selected from the group consisting of an unsubstituted or substituted alkyl, alkoxyalkyl, cycloalkyl, aryl, alkylaryl, heterocyclyl and heteroaryl, which process comprises reacting the carbonate with molecular hydrogen (H 2 ), in the presence of a Ruthenium complex represented by the structure of formula A1′, A2′ or A3′: wherein L 1 is N(R) 2 ; L 2 is selected from the group consisting of nucleophilic carbene (:CR 2 ), P(R 2 ) P(OR) 2 , N(R) 2 , imine, SR, SH, S(═O)R, heteroaryl wherein the heteroatom is selected from nitrogen and sulfur, As(R 2 ), Sb(R) 2 and an N-heterocyclic carbene represented by the structure: wherein each of R, R 1 , R 2 and R 3 are independently selected from the group consisting of alkyl, cycloalkyl, aryl, alkylaryl, heterocyclyl and heteroaryl; L 3 is a mono-dentate two-electron donor selected from the group consisting of CO, P(R) 3 , P(OR) 3 , NO + , As(R) 3 , Sb(R) 3 , S(R) 2 , nitrile (RCN) and isonitrile (RNC) wherein R is as defined above; L 4 is absent or is L 3 ; Y and Z are each independently H or an anionic ligand selected from the group consisting of halogen, OCOR, OCOCF 3 OSO 2 R OSO 2 CF 3 , CN, OH, OR, N(R 2 ), RS and SH; wherein R is as defined above; X represents zero, one, two or three substituents selected from the group consisting of alkyl, aryl, halogen, nitro, amide, ester, cyano, alkoxy, cycloalkyl, alkylaryl, heterocyclyl, heteroaryl, an inorganic support and a polymeric moiety; and anion represents a group bearing a single negative charge. 7. The process of claim 6 , wherein the carbonate is dimethyl carbonate, diethyl carbonate, dipropyl carbonate or dibutyl carbonate. 8. A process for hydrogenating a carbamate represented by the formula R 9 O—C(═O)—NHR 10 to the corresponding amine, alcohol and methanol: wherein R 9 is selected from the group consisting of an unsubstituted or substituted alkyl, alkoxyalkyl, cycloalkyl, aryl, alkylaryl, heterocyclyl and heteroaryl; and R 10 is selected from the group consisting of H or an unsubstituted or substituted alkyl, alkoxyalkyl, cycloalkyl, aryl, alkylaryl, heterocyclyl and heteroaryl, which process comprises reacting the carbamate with molecular hydrogen (H 2 ), in the presence of a Ruthenium complex represented by the structure of formula A1′, A2′ or A3′: wherein L 1 is N(R) 2 ; L 2 is selected from the group consisting of nucleophilic carbene (:CR 2 ), P(R 2 ) P(OR) 2 , N(R) 2 , imine, SR, SH, S(═O)R, heteroaryl wherein the heteroatom is selected from nitrogen and sulfur, As(R 2 ), Sb(R) 2 and an N-heterocyclic carbene represented by the structure: wherein each of R, R 1 , R 2 and R 3 are independently selected from the group consisting of alkyl, cycloalkyl, aryl, alkylaryl, heterocyclyl and heteroaryl; L 3 is a mono-dentate two-electron donor selected from the group consisting of CO, P(R) 3 , P(OR) 3 , NO + , As(R) 3 , Sb(R) 3 , S(R) 2 , nitrile (RCN) and isonitrile (RNC) wherein R is as defined above; L 4 is absent or is L 3 ; Y and Z are each independently H or an anionic ligand selected from the group consisting of halogen, OCOR, OCOCF 3 OSO 2 R OSO 2 C

Assignees

Inventors

Classifications

  • having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms · CPC title

  • having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton · CPC title

  • by reacting an ester group with a hydroxy group · CPC title

  • Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton · CPC title

  • Polyamines · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9290441B2 cover?
A process for preparing amides by reacting a primary amine and a primary alcohol in the presence of a Ruthenium complex to generate the amide and molecular hydrogen. Primary amines are directly acylated by equimolar amounts of alcohols to produce amides and molecular hydrogen (the only byproduct) in high yields and high turnover numbers. Also disclosed are processes for hydrogenation of amides …
Who is the assignee on this patent?
Milstein David, Gunanathan Chidambaram, Ben-David Yehoshua, and 4 more
What technology area does this patent fall under?
Primary CPC classification C07C209/50. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).